Retrorectal cystic hamartoma as benign cause of CA 19-9 elevationGARCIA-DONAS, Jesus; RODRIGUEZ, Nuria; JARA, Carlos et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 4012-4014, issn 0732-183X, 3 p.Article

Elevated carbohydrate antigen 19-9 in a dermoid cystATABEKOGLU, C; BOZACI, E. A; TEZCAN, S et al.International journal of gynaecology and obstetrics. 2005, Vol 91, Num 3, pp 262-263, issn 0020-7292, 2 p.Article

Predictive Value of Serum Carbohydrate Antigen 19-9 in Malignant Intraductal Papillary Mucinous NeoplasmsBIN XU; ZHENG, Wen-Van; JIN, Da-Yong et al.World journal of surgery. 2011, Vol 35, Num 5, pp 1103-1109, issn 0364-2313, 7 p.Article

Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant womenKOBAYASHI, F; SAGAWA, N; NAKAMURA, K et al.American journal of obstetrics and gynecology. 1989, Vol 160, Num 3, pp 563-566, issn 0002-9378Article

Interchangeability of measurements of CA 19-9 in serum with four frequently used assays : an updatePASSERINI, Rita; RIGGIO, Daniela; SALVATICI, Michela et al.Clinical chemistry and laboratory medicine. 2007, Vol 45, Num 1, pp 100-104, issn 1434-6621, 5 p.Article

Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosisHARADA, Tatsuya; KUBOTA, Toshiro; ASO, Takeshi et al.Fertility and sterility. 2002, Vol 78, Num 4, pp 733-739, issn 0015-0282, 7 p.Article

Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancerISHIGAMI, Sumiya; NATSUGOE, Shoji; AIKOU, Takashi et al.Journal of clinical gastroenterology. 2001, Vol 32, Num 1, pp 41-44, issn 0192-0790Article

Pancreatitis-associated protein (PAP) in patients with pancreatic cancerCERWENKA, Herwig; AIGNER, Reingard; BACHER, Heinz et al.Anticancer research. 2001, Vol 21, Num 2B, pp 1471-1474, issn 0250-7005Article

The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancerTANAKA, N; OKADA, S; UENO, H et al.Pancreas. 2000, Vol 20, Num 4, pp 378-381, issn 0885-3177Article

Extragonadal germ cell tumor of mediastinum with high serum level of carcinoembryonic antigen and carbohydrate antigen 19-9KITSUKAWA, S.-I; KIN, T; TSUKAMOTO, T et al.The Journal of urology. 2000, Vol 163, Num 3, pp 912-913, issn 0022-5347Article

Frequent expression of sialyl Le^a in human esophageal squamous cell carcinomaOSHIBA, G; KIJIMA, H; YAMAZAKI, H et al.International journal of oncology. 2000, Vol 17, Num 4, pp 701-705, issn 1019-6439Article

Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a caucasian populationVESTERGAARD, E. M; HEIN, H. O; MEYER, H et al.Clinical chemistry (Baltimore, Md.). 1999, Vol 45, Num 1, pp 54-61, issn 0009-9147Article

Performance characteristics of five automated CA 19-9 assaysLA'ULU, Sonia L; ROBERTS, William L.American journal of clinical pathology. 2007, Vol 127, Num 3, pp 436-440, issn 0002-9173, 5 p.Article

Prognostic relevance of carbohydrate antigen 19-9 levels in patients with advanced biliary tract cancerHARDER, Jan; KUMMER, Oliver; OLSCHEWSKI, Manfred et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 10, pp 2097-2100, issn 1055-9965, 4 p.Article

Some notes about statistical approaches adopted in assessing relationships between measurement methods of biomarkersMARUBINI, E; ARTUSI, R; VERDERIO, P et al.The International journal of biological markers. 2001, Vol 16, Num 3, pp 199-200, issn 0393-6155Conference Paper

The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinomaNAZLI, Okay; BOZDAG, Ali Dogan; TANSUG, Tugrul et al.Hepato-gastroenterology. 2000, Vol 47, Num 36, pp 1750-1752, issn 0172-6390Article

Clinicopathological features in misdiagnosed pancreatic carcinomaNAGAHAMA, H; OKADA, S; OKUSAKA, T et al.Hepato-gastroenterology. 1999, Vol 46, Num 29, pp 2983-2985, issn 0172-6390Article

Detection of pancreatic carcinoma : Diagnostic value of K-ras mutations in circulating DNA from serumTHEODOR, L; MELZER, E; SOLOGOV, M et al.Digestive diseases and sciences. 1999, Vol 44, Num 10, pp 2014-2019, issn 0163-2116Article

Adénocarcinome du pancréas : le dosage du CA 19-9 a-t-il un intérêt ? = Adenocarcinoma of the pancreas : are CA 19-9 assays useful?LEVY, Philippe.La Presse médicale (1983). 2008, Vol 37, Num 1, pp 88-94, issn 0755-4982, 7 p., CAH2Article

A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer : Analysis using a receiver operating characteristic curveKIM, H.-J; KIM, M.-H; MYUNG, S.-J et al.The American journal of gastroenterology. 1999, Vol 94, Num 7, pp 1941-1946, issn 0002-9270Article

Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for α-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinomaOKUDA, Hiroaki; SHIRATORI, Keiko; YAMAMOTO, Masakazu et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 5, pp 869-873, issn 0815-9319, 5 p.Article

PAM4 Enzyme Immunoassay Alone and in Combination With CA 19-9 for the Detection of Pancreatic AdenocarcinomaGOLD, David V; GAEDCKE, Jochen; MICHAEL GHADIMI, B et al.Cancer. 2013, Vol 119, Num 3, pp 522-528, issn 0008-543X, 7 p.Article

Carbohydrate Antigen 19-9 Change During Chemotherapy for Advanced Pancreatic AdenocarcinomaRENI, Michele; CEREDA, Stefano; BALZANO, Gianpaolo et al.Cancer. 2009, Vol 115, Num 12, pp 2630-2639, issn 0008-543X, 10 p.Article

Further evidence for prolongation of survival of pancreatic cancer patients by efficacy orientated sequential polychemotherapy (EOSPC) based on serial tumor marker determinations (CA 19-9/CEA)KLAPDOR, R; BAHLO, M; BABINSKY, A et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1687-1691, issn 0250-7005, 5 p.Article

Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?KAYHAN, B; AKDOGAN, M.The International journal of biological markers. 2004, Vol 19, Num 3, pp 196-202, issn 0393-6155, 7 p.Article